231 An In Vitro Pharmacodynamic Model of a Human Simulated High Dose, Prolonged Infusion Meropenem Regimen against Klebsiella spp. producing the KPC Carbapenemase

Sunday, April 26, 2009
Catharine C. Bulik, Pharm.D. , Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT
Henry Christensen, BS , Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT
Peng Li, BS(Pharm) , Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT
David P. Nicolau, Pharm.D., FCCP, FIDSA , Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT
Joseph L. Kuti, Pharm.D. , Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT